Anterior enclavation
ProcedureAnterior enclavation of iris-claw lens
NCT Number: NCT06396156
The Artisan lens (Artisan Aphakic, Ophtec BV) is an iris- claw lens designed for implantation in children with insufficient capsular support. In spite of less surgical manipulations and a relatively shorter operation time, the procedure carries the risk of corneal endothelial cell loss or dis-enclavation, particularly in children. However, most of the studies that studied iris-claw lenses in aphakic children were retrospective evaluated only a single technique; either anterior or retropupillary fixation, or comparable to other techniques of fixation. Thus the aim of this work is to prospectively compare the 2 techniques of iris-claw lens implantation and their effects on central endothelial cell density, the anatomical and visual outcome, as well as the complications' rate.
Looking for future studies?
Notify Me2 year–18 year
All sexes
Interventional
Not applicable
Cairo University, Cairo, Egypt
Children for the study will be recruited from the Pediatric Ophthalmology Clinics in Cairo University Hospitals. Children will be included if they have aphakia with insufficient capsular support, hereditary lens subluxation. microspherophakia . or traumatic lens subluxation > 180 degrees that requires lensectomy and intraocular lens implantation .
Patients recruited for this study will be assigned into 2 groups:
Preoperative Evaluation
Demographics and History Taking Baseline demographic data will be collected from all patients including
Systemic Workup:
Patients without evidence of trauma had a complete workup in conjunction with a pediatrician for the underlying cause of subluxation or absent capsular support
Ocular Examination:
Evaluation of the cornea for clarity and regularity Evaluation of the anterior chamber Evaluation of the iris for - Iris structure and iris defects - Tremulousness
Evaluation of corneal endothelium:
Corneal endothelial cell count (ECC) will be evaluated using non-contact Specular Microscope (Konan Medical KSS-300, Inc., Hyogo, Japan) for all children. only sharp images with easily identified cell borders will be analyzed. The endothelial cell density (ECD) will be calculated with center method in all images. Fixed number of cells will be used in all scans to eliminate variability. Manual selection of cells will be performed in all scans. A single island of contiguous cells with well identified borders will be used for calculations.
Anterior Segment Optical Coherence Tomography (AS-OCT):
All subject eyes will be scanned with a hand-held anterior segment optical coherence tomography (HH AS-OCT); RTVue RT-100 system (Optovue Inc., Fremont, CA). A non-contact technique will be used for scanning, with the child lying supine without sedation. All scans will be performed with the pupil undilated and under mesopic conditions. each eye will be imaged at least 3 scans per visit.
Corneal thickness mapping:
A pachymetry scan pattern, with 6-mm scan diameter and eight radials, will be chosen to map the cornea. The RTVue corneal adapter module software provided the pachymetry map of total corneal thickness, automatically. Central corneal thickness will be automatically calculated in µm as the central distance between the epithelium and endothelium.
Anterior chamber angle assessment:
Scanning of the angle will be performed on the nasal and temporal quadrants at 3 and 9 o'clock under mesopic conditions with the device's software set to Angle mode. In this mode, a 3 x 2.3 mm area centered at the limbus will be analyzed. Each quadrant will be scanned three times, and the investigator will choose the image showing the best quality and least noise.
Angle abnormalities including abnormal angle membrane, peripheral anterior synechiae (PAS), primary congenital glaucoma (PCG) like changes will be documented in pre and postoperative scans.
IOL power calculation:
IOL power calculation will be performed using optical biometry. In uncooperative children and children in whom optical biometry could not be performed, an A-scan biometry will be performed using contact technique. IOL power will be calculated using either SRK-T and Holladay 1 formula. An A constant of 115.7 and 116.8 will be assigned for the anterior chamber and posterior iris-claw lens, respectively. Emmetropia will be targeted in all patients.
Surgical technique:
All surgeries will be performed under general anesthesia. In all the eyes that required lensectomy, the procedure will be performed through an anterior corneal approach. A 23-gauge MVR knife will be used to create two side ports at 3 o'clock and 9 o'clock. A cohesive viscoelastic will be injected in retrolenticular space. Then, the MVR blade will be used to create 2 incisions at the equator of the subluxated lens, and slightly widened. A 23-gauge bimanual irrigation and aspiration system will be used to aspirate lens matter. Then a 23-G vitrectomy probe will be used for lens capsule removal. Sweeping of anterior chamber using spatula will be performed to ensure the absence of vitreous strands. Miosis will be achieved by injecting intra-cameral pilocarpine 1% then a peripheral iridectomy at 11 or 1 o'clock will be performed using the vitrector probe. A cohesive viscoelastic will be injected, and then a superior limbal corneal incision of 6 mm will be constructed, but not opened. In Group A, anterior chamber iris claw fixation will be done. The lens will be introduced using the curved Clayman forceps with its vault facing up, and then enclavated at 3 and 9 o'clock positions anterior to the iris. In the retropupillary group (Group B), the IOL will be introduced behind the pupil and enclavated behind the iris. Corneal wounds will be them closed using 10/0 nylon sutures.
Postoperative regimen:
Topical steroids and antibiotics will be prescribed for 6-8 weeks after surgery. Topical tropicamide 1% will be prescribed to be used twice per day for 1 week to decrease pigment dispersion. Removal of sutures will be done 6 weeks after surgery.
Postoperative Follow-Up:
Patients will be followed up at 1 day, 1 week, 1 month, 6 months, and 12 months after surgery. More frequent follow-up will be performed whenever needed.
<!-- -->
All patients will be examined on the first day after surgery for o Corneal clarity o Anterior chamber reaction and pigment dispersion o Stability and centration of the IOL o Patency of the peripheral iridectomy
o IOP measurement Clinical examination will be then repeated at each follow-up visit
A dilated refraction will be performed 2 weeks after suture removal (8 weeks after surgery), Any residual refractive error will be corrected fully in all patients using single vision glasses. In older children, bifocal spectacles will be prescribed.
UBM scanning (VuMAX HD, Sonomed Escalon, New York) will be performed at the end of 1-year follow-up. Examination will be performed with the patient in the supine position to measure IOL tilt and decentration.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Anterior enclavation of iris-claw lens
Posterior enclavation of iris-claw lens
Time frame: 1 year
Percentage of endothelial cell loss from the baseline value
Time frame: 1 year
Best-corrected distance log-MAR visual acuity
Time frame: 1 year
Width of anterior chamber angle by OCT
Time frame: 1 year
Measured intraocular pressure by applanation
Time frame: 1 year
Degree of tilt of intraocular lens measured by UBM
Time frame: 1 year
Degree of decentration of lens measured by UBM
Cairo University
Other
Anterior Chamber Versus Retropupillary Iris-claw Intraocular Lens Fixation in Aphakic Children With Insufficient Capsular Support.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05724446
Cataracts Infantile, Inflammation
Barcelona, Spain
View Trial DetailsNCT07718100
Corneal Diseases, Corneal Endothelial Cell Loss
Van, Turkey (Türkiye)
View Trial DetailsNCT02128113
Cataract Surgery, Corneal Diseases
Laguna Hills, California, United States
View Trial DetailsNCT03107000
Corneal Diseases, Corneal Endothelial Cell Loss
Toronto, Ontario, Canada
View Trial Details